Published • loading... • Updated
PTC Therapeutics (NASDAQ:PTCT) Director Sells 12,000 Shares of Stock
Summary by insidertrades.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
thecerbatgem.comReposted by 
insidertrades.com
insidertrades.comPTC Therapeutics (NASDAQ:PTCT) Director Sells 12,000 Shares of Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) Director Glenn Md Phd Steele, Jr. sold 12,000 shares of the firm’s stock in a transaction dated Wednesday, September 30th. The shares were sold at an average price of $65.16, for a total value of $781,920.00. Following the sale, the director owned 22,500 shares in the company, […]
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
